Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Cancers
|
May 25, 2024
Frequency of Common and Uncommon <i>BRAF</i> Alterations among Colorectal and Non-Colorectal Gastrointestinal Malignancies
Amit Mahipal, Michael H Storandt, Emily A Teslow, et al.
Clinical Lung Cancer
|
March 10, 2025
Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers
Radhika Gutta, Emily Teslow, Ellen Jaeger, et al.
NPJ Precision Oncology
|
July 4, 2025
Genetic and oncogenic features of RASGRF fusions
Sreya Das, Daniel S Lenchner, Ellen Jaeger, et al.
International Journal of Molecular Sciences
|
July 28, 2022
3D Printed Solutions for Spheroid Engineering and Cancer Research
Tobias Butelmann, Yawei Gu, Aijun Li, et al.
The Oncologist
|
October 9, 2022
Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression on Novel Hormonal Therapies plus Avelumab
Charlotte Manogue Hawkins, Pedro C Barata, Patrick Cotogno, et al.
Cancers
|
May 14, 2025
Germline DNA Repair Gene Mutations and Clonal Hematopoiesis (CH) in 24,849 Patients with BRCA-Associated Cancers
Catherine H Marshall, Ali T Arafa, Ellen Jaeger, et al.
The Prostate
|
March 24, 2021
Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients
Rachel A Sabol, Elisa M Ledet, Ellen Jaeger, et al.
Frontiers in Oncology
|
November 16, 2020
Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort
Pedro Barata, Whitley Hatton, Arpita Desai, et al.
Journal for Immunotherapy of Cancer
|
August 14, 2020
Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA
Pedro Barata, Neeraj Agarwal, Roberto Nussenzveig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2025
ESR1 Y537S and D538G Mutations Drive Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
Chang-Ching A Lin, María Rosario Chica-Parrado, Nisha Unni, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Cancers
|
May 25, 2024
Frequency of Common and Uncommon <i>BRAF</i> Alterations among Colorectal and Non-Colorectal Gastrointestinal Malignancies
Amit Mahipal, Michael H Storandt, Emily A Teslow, et al.
Clinical Lung Cancer
|
March 10, 2025
Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers
Radhika Gutta, Emily Teslow, Ellen Jaeger, et al.
NPJ Precision Oncology
|
July 4, 2025
Genetic and oncogenic features of RASGRF fusions
Sreya Das, Daniel S Lenchner, Ellen Jaeger, et al.
International Journal of Molecular Sciences
|
July 28, 2022
3D Printed Solutions for Spheroid Engineering and Cancer Research
Tobias Butelmann, Yawei Gu, Aijun Li, et al.
The Oncologist
|
October 9, 2022
Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression on Novel Hormonal Therapies plus Avelumab
Charlotte Manogue Hawkins, Pedro C Barata, Patrick Cotogno, et al.
Cancers
|
May 14, 2025
Germline DNA Repair Gene Mutations and Clonal Hematopoiesis (CH) in 24,849 Patients with BRCA-Associated Cancers
Catherine H Marshall, Ali T Arafa, Ellen Jaeger, et al.
The Prostate
|
March 24, 2021
Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients
Rachel A Sabol, Elisa M Ledet, Ellen Jaeger, et al.
Frontiers in Oncology
|
November 16, 2020
Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort
Pedro Barata, Whitley Hatton, Arpita Desai, et al.
Journal for Immunotherapy of Cancer
|
August 14, 2020
Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA
Pedro Barata, Neeraj Agarwal, Roberto Nussenzveig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2025
ESR1 Y537S and D538G Mutations Drive Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
Chang-Ching A Lin, María Rosario Chica-Parrado, Nisha Unni, et al.
Page
of 2